TANITOL Trademark

Trademark Overview


On Thursday, December 11, 2014, a trademark application was filed for TANITOL with the United States Patent and Trademark Office. The USPTO has given the TANITOL trademark a serial number of 86477261. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 10, 2023. This trademark is owned by InQpharm Europe Limited. The TANITOL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and nutraceutical preparations for the treatment of metabolic syndrome and related diseases, general weight management, treatment of obesity and prevention of obesity; pharmaceutical, nutraceutical and other preparations in the nature of chemical preparations for the treatment of metabolic syndrome and related diseases, general weight management and treatment of obesity; chemical preparations for medical and pharmaceutical purposes for the treatment of metabolic syndrome and related diseases, general weight management, treatment of obesity and prevention of obesity; dietary supplement; plant extracts adapted for dietetic, nutraceutical, healthcare, medical, nutritional and pharmaceutical use including for the treatment of metabolic syndrome and related diseases, general weight management, treatment of obesity and blood glucose management; pharmaceutical, nutraceutical and other preparations in the nature of chemical preparations for blood glucose management; medicated fo...
tanitol

General Information


Serial Number86477261
Word MarkTANITOL
Filing DateThursday, December 11, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 10, 2023
Registration Number5008763
Registration DateTuesday, July 26, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 27, 2015

Trademark Statements


Goods and ServicesPharmaceutical and nutraceutical preparations for the treatment of metabolic syndrome and related diseases, general weight management, treatment of obesity and prevention of obesity; pharmaceutical, nutraceutical and other preparations in the nature of chemical preparations for the treatment of metabolic syndrome and related diseases, general weight management and treatment of obesity; chemical preparations for medical and pharmaceutical purposes for the treatment of metabolic syndrome and related diseases, general weight management, treatment of obesity and prevention of obesity; dietary supplement; plant extracts adapted for dietetic, nutraceutical, healthcare, medical, nutritional and pharmaceutical use including for the treatment of metabolic syndrome and related diseases, general weight management, treatment of obesity and blood glucose management; pharmaceutical, nutraceutical and other preparations in the nature of chemical preparations for blood glucose management; medicated food supplements; weight management supplements; nutraceuticals for use as a dietary supplement; nutritional supplements for eliminating fats, carbohydrates and/or sugars from the body or digestive system; diet pills, namely, fat, carbohydrate and/or sugar blockers or binders; nutritional supplements for reducing or inhibiting the absorption of fats, carbohydrates and/or sugars in the body or digestive system; nutritional food additives for medical purposes in the nature of food extracts derived from plant extracts

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 10, 2023
Primary Code005
First Use Anywhere DateTuesday, November 10, 2015
First Use In Commerce DateWednesday, December 16, 2015

Trademark Owner History


Party NameInQpharm Europe Limited
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressHitchin, Hertfordshire SG40TY
GB

Party NameInQpharm Europe Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHitchin, Hertfordshire SG40TY
GB

Party NameInQpharm Europe Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHitchin, Hertfordshire SG40TY
GB

Trademark Events


Event DateEvent Description
Friday, February 10, 2023CANCELLED SEC. 8 (6-YR)
Monday, July 26, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 26, 2016REGISTERED-PRINCIPAL REGISTER
Thursday, June 23, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, June 22, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, June 2, 2016STATEMENT OF USE PROCESSING COMPLETE
Wednesday, May 4, 2016USE AMENDMENT FILED
Friday, May 27, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 4, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, December 22, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 27, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 27, 2015PUBLISHED FOR OPPOSITION
Wednesday, October 7, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 22, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, September 21, 2015ASSIGNED TO LIE
Tuesday, August 25, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 25, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 24, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 24, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 24, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 24, 2015NON-FINAL ACTION E-MAILED
Tuesday, March 24, 2015NON-FINAL ACTION WRITTEN
Tuesday, March 24, 2015ASSIGNED TO EXAMINER
Monday, December 15, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 15, 2014NEW APPLICATION ENTERED